- Conditions: Healthy Infants; Immunization; Pain Management
Intervention: Behavioral: Tactile stimulation
Sponsors: University of Toronto; University of Toronto
Not yet recruiting - verified May 2012 - Condition: Prediabetes
Intervention: Behavioral: Lifestyle changes
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified April 2012 - Condition: Muscle Development
Interventions: Dietary Supplement: Whey protein; Dietary Supplement: Chocolate milk; Dietary Supplement: Sugar
Sponsors: University of Manitoba; University of Manitoba
Recruiting - verified April 2012 - Condition: Pharmacodyamics and Pharmacokinetics of Tasimelteon Alone and in Combination With Ethanol
Interventions: Drug: tasimelteon; Drug: Ethanol; Other: Placebo tasimelteon; Drug: Placebo ethanol
Sponsors: Vanda Pharmaceuticals; Vanda Pharmaceuticals
Recruiting - verified April 2012 - Conditions: Type 2 Diabetes Mellitus; Gestational Diabetes
Interventions: Device: Continuous Glucose Monitoring; Device: Glucose Meter
Sponsors: Lawson Health Research Institute; Dr. Stewart Harris; Juvenile Diabetes Research Foundation
Not yet recruiting - verified April 2012 - Condition: Healthy
Intervention: Dietary Supplement: protein intake. On the study day, the diet will be provided as free amino acids, with calories made up by a liquid diet and protein free cookies.
Sponsors: The Hospital for Sick Children; The Hospital for Sick Children; Canadian Institutes of Health Research (CIHR)
Recruiting - verified April 2012 - Condition: Drug Mechanism
Intervention: Drug: Lithium Carbonate
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Not yet recruiting - verified April 2012 - Condition: Drug Abuse
Intervention: Drug: 45-mg hydrocodone bitartrate extended-release tablet (crushed or intact)
Sponsors: Teva Pharmaceutical Industries; Cephalon
Recruiting - verified May 2012 - Condition: Healthy
Interventions: Dietary Supplement: Fish Oil; Dietary Supplement: PCSO-524
Sponsors: Nutrasource Diagnostics Inc.; Nutrasource Diagnostics Inc.; Pharmalink International Ltd.
Not yet recruiting - verified March 2012 - Condition: Coronary Artery Disease
Intervention: Drug: 123I-CMICE-013
Sponsors: University of Ottawa Heart Institute; University of Ottawa Heart Institute; Canadian Institutes of Health Research (CIHR)
Recruiting - verified April 2012 - Conditions: Hepatitis C; Hypertension
Interventions: Drug: Amlodipine; Drug: Diltiazem
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Merck
Not yet recruiting - verified March 2012 - Condition: Healthy Volunteer
Interventions: Drug: MCAF5352A; Drug: Placebo
Sponsors: Genentech; Genentech
Recruiting - verified March 2012 - Condition: Healthy
Intervention: Dietary Supplement: omega-3 fatty acids
Sponsors: Universitaire de Sherbrooke; Universitaire de Sherbrooke
Recruiting - verified February 2012 - Condition: Healthy Children
Intervention: Other: nutrition
Sponsors: McMaster University; McMaster University; Nestec Ltd.
Recruiting - verified May 2012 - Conditions: Advanced Cancer; Healthy
Intervention:
Sponsors: University Health Network, Toronto; University Health Network, Toronto
Not yet recruiting - verified March 2012 - Conditions: Moderate to Severe Alzheimer; Alzheimer Disease
Interventions: Drug: RPh201, botanical drug product; Drug: Placebo; Drug: RPh201, botanical extract product; Drug: Placebo
Sponsors: Regenera Pharma Ltd; Regenera Pharma Ltd; Kendle Toronto, Inc, a wholly-owned subsidiary of INC Research LLC
Recruiting - verified January 2012 - Conditions: Obesity; Genetic Disorder; Mental Retardation; Developmental Delay
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified November 2011 - Conditions: Diabetes Mellitus, Type 2; Hypercholesterolemia
Intervention: Other: BeneFlax - 38% secoisolariciresinol diglucoside (SDG)
Sponsors: University of Saskatchewan; University of Saskatchewan; Saskatchewan Health Research Foundation
Recruiting - verified February 2012 - Condition: Pneumococcal Infections
Interventions: Biological: Pneumococcal Conjugate Vaccine (V114); Biological: Pneumococcal Polysaccharide Vaccine; Biological: Pneumococcal 13-Valent Conjugate Vaccine
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Acne
Intervention: Drug: Lemuteporfin
Sponsors: Dermira, Inc.; Dermira, Inc.
Recruiting - verified December 2011 - Condition: Healthy Volunteer
Interventions: Drug: MCAF5352A; Drug: Placebo
Sponsors: Genentech; Genentech
Recruiting - verified December 2011 - Condition: Healthy Metabolism
Intervention: Drug: Amantadine
Sponsors: University of Manitoba; University of Manitoba; St. Boniface General Hospital Research Centre
Recruiting - verified November 2011 - Condition: Schizophrenia
Interventions: Drug: Nicotine polacrilex; Drug: Regular chewing gum; Dentyne Ice, Wrigely´s Mint Gum
Sponsors: Centre for Addiction and Mental Health; Centre for Addiction and Mental Health
Recruiting - verified January 2012 - Condition: Healthy
Interventions: Other: Avene Compact Honey SPF 50; Other: No intervention
Sponsors: Pierre Fabre Dermo Cosmetique; Pierre Fabre Dermo Cosmetique
Recruiting - verified October 2011 - Conditions: Streptococcal Infection; Gram-positive Bacterial Infection; Bacterial Infection
Interventions: Biological: Group B streptococcus vaccine; Biological: Placebo
Sponsors: Novartis; Novartis; Novartis Vaccines
Recruiting - verified May 2012 - Conditions: Healthy; High Velocity Fracture; Cranial Trauma; Spinal Trauma
Intervention:
Sponsors: Centre Hospitalier Universitaire de Sherbrooke; Centre Hospitalier Universitaire de Sherbrooke; Universitaire de Sherbrooke; Canadian Institutes of Health Research (CIHR)
Recruiting - verified September 2011 - Condition: Healthy
Interventions: Dietary Supplement: All Greens; Other: Control Formulation
Sponsors: University of British Columbia; University of British Columbia; Factors Group of Nutritional Companies; QualityMetrics
Recruiting - verified April 2012 - Conditions: Renin Angiotensin System; Human; Renal Hemodynamics
Intervention: Dietary Supplement: Fructose
Sponsors: University of Calgary; University of Calgary
Recruiting - verified July 2011 - Condition: Healthy
Interventions: Drug: Trazodone; Drug: Quetiapine; Drug: Pindolol; Procedure: Blood Collection
Sponsors: University of Ottawa; University of Ottawa
Recruiting - verified July 2011 - Condition: Malignant Lymphoma, Stem Cell Type
Interventions: Drug: Plerixafor (Mozobil); Drug: Plerixafor + G-CSF
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; Genzyme
Not yet recruiting - verified July 2011 - Condition: Prediabetes
Interventions: Behavioral: PREPARE education program; Other: standard of care presentation
Sponsors: Brescia University College; Brescia University College
Recruiting - verified July 2011 - Condition: Clostridium Difficile Infection
Intervention: Biological: "synthetic stool" or pure cultures of probiotic intestinal bacteria
Sponsors: Queen's University; Queen's University; The Physicians' Services Incorporated Foundation
Recruiting - verified April 2012 - Conditions: Healthy; Obesity
Interventions: Behavioral: 2 servings of dairy/day and exercise counselling; Behavioral: 4 servings of dairy/day and exercise counselling
Sponsors: McGill University; McGill University; Dairy Farmers of Canada
Recruiting - verified March 2012 - Conditions: Asthma; Health
Intervention: Other: All patients
Sponsors: Centocor, Inc.; Centocor, Inc.
Recruiting - verified April 2012 - Condition: Healthy Young and Elderly Volunteers
Interventions: Drug: Intravenous Citalopram; Drug: Normal Saline
Sponsors: Rotman Research Institute at Baycrest; Rotman Research Institute at Baycrest; Centre for Addiction and Mental Health; University of Toronto
Recruiting - verified January 2012 - Conditions: Human Papillomavirus (HPV) Type 16/18 Infections; Cervical Neoplasia
Intervention: Biological: GSK580299 (Cervarix™)
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified February 2012 - Condition: Healthy
Intervention: Drug: Desvenlafaxine succinate
Sponsors: University of Ottawa; University of Ottawa
Recruiting - verified April 2010 - Condition: Scoliosis
Interventions: Procedure: Surgical intervention; Other: Non operative intervention
Sponsors: Washington University School of Medicine; Washington University School of Medicine; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Northwestern University; New York University; University of Virginia; University of Louisville; Maryland Spine Center; Hospital for Special Surgery, New York; University Health Network, Toronto; Hopital du Sacre', Montreal University; Dartmouth-Hitchcock Medical Center
Recruiting - verified April 2012 - Condition: Glioma
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified April 2012 - Conditions: Poliomyelitis; Haemophilus Influenzae Type b Disease; Hepatitis B; Diphtheria; Pertussis; Tetanus
Intervention: Biological: Infanrix™ hexa
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified August 2011 - Condition: Retinoblastoma
Interventions: Genetic: DNA ploidy analysis; Genetic: DNA stability analysis; Genetic: Southern blotting; Genetic: genetic linkage analysis; Genetic: loss of heterozygosity analysis; Genetic: mutation analysis; Genetic: polymorphism analysis; Genetic: reverse transcriptase-polymerase chain reaction; Other: environmental carcinogenesis study; Other: questionnaire administration; Other: study of socioeconomic and demographic variables; Procedure: evaluation of cancer risk factors; Procedure: mutation carrier screening
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Condition: Healthy
Interventions: Device: repetitive transcranial magnetic stimulation (rTMS); Device: repetitive transcranial magnetic stimulation (rTMS); Device: sham repetitive transcranial magnetic stimulation (rTMS)
Sponsors: Centre for Addiction and Mental Health; Centre for Addiction and Mental Health
Recruiting - verified May 2012 - Conditions: Amnestic Mild Cognitive Impairment; Aging
Interventions: Behavioral: Recollection Training; Behavioral: Control
Sponsors: Baycrest; Baycrest
Recruiting - verified September 2011 - Condition: Healthy
Intervention:
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified December 2011 - Condition: Non-small Cell Lung Cancer
Intervention:
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified November 2011

Clinical Trial Locations 